Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.70% | -10.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.70% | -10.07% | |||
| Cost of Revenue | 37.62% | -12.82% | |||
| Gross Profit | 1.72% | -9.38% | |||
| SG&A Expenses | -11.37% | 15.59% | |||
| Depreciation & Amortization | 3.25% | -2.58% | |||
| Other Operating Expenses | 6.15% | -19.84% | |||
| Total Operating Expenses | 4.30% | 4.30% | |||
| Operating Income | 26.74% | -42.50% | |||
| Income Before Tax | 774.46% | -110.05% | |||
| Income Tax Expenses | 919.72% | -107.82% | |||
| Earnings from Continuing Operations | 753.37% | -110.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 753.37% | -110.48% | |||
| EBIT | 26.74% | -42.50% | |||
| EBITDA | 19.12% | -33.94% | |||
| EPS Basic | 751.22% | -110.47% | |||
| Normalized Basic EPS | 24.86% | -43.50% | |||
| EPS Diluted | 745.06% | -110.51% | |||
| Normalized Diluted EPS | 23.85% | -43.30% | |||
| Average Basic Shares Outstanding | 0.34% | 0.07% | |||
| Average Diluted Shares Outstanding | 1.16% | -0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||